Buy a Clinical Laboratory: How Lab Acquisitions Are Financed
For laboratory professionals, pathologists and healthcare investors, the decision to buy a clinical laboratory can be a direct path to an established test menu, client base, trained staff and payer relationships. Building those pieces from scratch can take years, while an acquisition may provide them on day one.
Laboratory acquisitions also carry risks that ordinary business purchases do not, from certification and payer enrollment issues to billing compliance history. This guide explains how lab acquisitions are typically evaluated and financed. Certification, licensing and billing rules vary by state and payer, and nothing here is legal, tax, billing or compliance advice.
Why Buyers Choose to Buy a Clinical Laboratory
Buyers pursue lab acquisitions for different reasons:
- Pathology groups: adding clinical testing to an anatomic pathology practice
- Laboratory managers and directors: moving from employment to ownership
- Existing lab owners: adding a new region, client base or specialty menu
- Physician groups: bringing outside testing in-house, subject to review by healthcare counsel
Each buyer brings different strengths, and lenders will weigh the buyer’s experience against the type of lab being purchased.
What Lenders Look at in the Target Lab
Lenders generally start with documented cash flow. They want to see several years of tax returns, financial statements, test volume reports, revenue by payer and client, accounts receivable aging and denial trends.
Beyond the numbers, lenders often focus on:
- Client concentration: how much volume comes from a few physician groups, facilities or contracts
- Payer mix: reliance on Medicare, Medicaid, commercial insurers or client billing
- Test menu: whether revenue depends on routine testing or a small number of specialty tests
- Reimbursement exposure: sensitivity to fee schedule changes
- Compliance history: past audits, payer reviews, recoupments or investigations
- Key personnel: whether the director and senior staff will stay after closing
Specialty labs, especially toxicology and genetic testing labs, may receive closer scrutiny. Our article on buying a toxicology lab explains the compliance risks lenders review in that segment.
Valuation and Purchase Price
The price a buyer can finance is ultimately tied to the cash flow the lab can sustain under new ownership. Value is generally driven by the stability of earnings, payer and client diversification, the depth of the test menu, the condition of equipment and the strength of the compliance program.
Sellers sometimes present adjusted earnings that add back owner expenses. Buyers and lenders should verify each adjustment with documentation. Our guide to clinical laboratory valuation covers what drives lab value in more depth.
Deal Structure and Certification
Labs may be purchased as an asset sale or by acquiring the ownership interests of the entity that operates the lab. Structure affects liability exposure, tax treatment, contract assignments and how certification and payer enrollments are handled.
CLIA certificates, state licenses, payer contracts and Medicare and Medicaid enrollments should not be assumed to transfer automatically. Change-of-ownership notices and new enrollments may be required, and claims can be delayed while they are processed. Our article on CLIA change of ownership explains how this affects the transaction. Healthcare counsel should guide the structure.
Financing Options When You Buy a Clinical Laboratory
Most buyers finance part of the purchase price rather than paying entirely in cash. Depending on the transaction, options may include:
- SBA 7(a) loans: SBA 7(a) financing may be used for the acquisition of an existing business and, in some cases, working capital and related real estate. Eligibility and terms depend on the business, the buyer, use of proceeds, program rules and lender review.
- Conventional acquisition loans: follow a lender’s own underwriting and may suit experienced buyers with strong credit and liquidity.
- Equipment financing: may be used separately for instruments purchased or upgraded after closing.
- Seller financing: a seller note may cover part of the price. Lenders and programs may limit seller notes and earnouts, and seller notes are typically subordinate to the senior loan.
Buyers can estimate potential payments with our SBA loan calculator. Estimates are for planning purposes only and do not represent an offer or approval.
Due Diligence Checklist
Due diligence for a lab acquisition typically covers:
- Financial statements, tax returns and bank statements
- Revenue and volume by test, client and payer
- Accounts receivable, denials and collection history
- Billing practices, documentation and medical necessity processes, reviewed by qualified billing or compliance professionals
- Client service agreements and any arrangements with referral sources, reviewed by healthcare counsel
- Certification, licensure, proficiency testing and inspection history
- Equipment condition, leases and reagent agreements
- Facility lease terms and landlord consent
Findings can affect price, structure or whether the buyer proceeds.
Planning the Transition
Even a healthy lab can experience a cash squeeze after closing. Enrollment updates may delay certain claims, clients may need reassurance and staff may need retention incentives. Building working capital into the financing request can provide flexibility during this period.
A transition plan should also cover client communication, continuity of the laboratory director, IT and interface changes and courier routes. Buyers who document this plan before closing can show lenders that they have considered how revenue will be protected during the first period of ownership.
Final Thoughts
When you buy a clinical laboratory, you are buying a test menu, a client base, a compliance record and a set of payer relationships that may need to be rebuilt in your name. Understanding each of those pieces, along with the financing structure, can help a buyer avoid surprises and close with confidence.
US Medical Funding helps buyers finance laboratory and pathology acquisitions. Learn more about our lab and pathology acquisition financing and our full range of laboratory and pathology financing options.
